Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SC Light Drop is a medical cannabis flower product developed and distributed by DEMECAN. It is derived from the 'Mimosa' cultivar, a Sativa-dominant hybrid strain created by crossing Clementine and Purple Punch. SC Light Drop typically contains approximately 19% to 20% tetrahydrocannabinol (THC) and less than 1% cannabidiol (CBD). It is prescribed for the treatment of various conditions, including depression, anxiety, appetite loss, and chronic stress. The therapeutic effects of SC Light Drop are mediated through the interaction of its active cannabinoids, primarily THC, with cannabinoid receptors CB1 and CB2 in the endocannabinoid system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SC Light Drop.